Beta-Blocker Therapy After Acute Myocardial Infarction
Historically, beta-blockers have long represented a cornerstone of secondary prevention after acute myocardial infarction (AMI). However, the transition to the modern era of early reperfusion and potent pharmacotherapy has questioned their universal efficacy, particularly in patients without post-AMI left ventricular d...